Program

Program 14th Co-infection workshop - downloadable

 

Pre-workshop Educational Course
Wednesday 16 May

 9:30HCV in 2018
Jürgen Rockstroh, MD, University of Bonn, Germany
 9:55HBV: diagnostics, management and screening
Marion Peters, MD, Mount Sinai Medical Centre, New York, NY, USA
 10:20Discussion
 10:30Coffee break
 11:05Liver care in HIV - management of abnormal LFTs
Juan Berenguer, MD, PHD, Hospital General Universitario Gregorio Marañón, Madrid, Spain
 11:30NAFLD: diagnostics, management and screening
Juan Macias, MD, PhD, Hospital de Valme, Seville, Spain
 11:50Fibrosis Markers and Cirrhosis management in HIV patients
 12:15Discussion
 12:30Lunch
 

14th International Workshop on Co-infection: HIV, Hepatitis and Liver Disease

 14:00Opening
  Session 1: Management of Hepatitis C - part 1
 14:05DAA: will generics change the landscape?
Sabela Lens, MD, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain
 14:35Abstract - driven presentations
 15:35Group picture
  15:50Coffee break
 16:30Industry-sponsored Symposium
 17:30Poster viewing session and welcome drinks
 

Thursday 17 May 2018

  Session 2: Management of Hepatitis C - part 2
 09:00HCV care after cure
Raffaele Bruno, MD, University of Pavia, Italy
 09:30Abstract - driven presentations
 10:15Discussion
 10:30Coffee break
 Session 3: Management of Hepatitis B - part 1
 11:00HBV managment in HIV patients 
Karine Lacombe, MD, PhD, Hôpital Saint Antoine Paris, France
 11:25HBV Novel Therapies
Maria Buti, MD,PHD Hospital Universitario Valle Hebron, Barcelona, Spain
  11:50Discussion
 Session 4: Best of Posters
 12:056-8 Best of Posters
 13:00Lunch
 Session 5: Management of Hepatitis B - part 2
 14:00Debate: TDF vs. TAF in HBV management
Mark Nelson, MD, Chelsea and Westminster Hospital, London, UK
Douglas Dieterich, MD, Mount Sinai Medical Centre, New York, NY, USA
 14:35Case on HEV
Antonio, Rivero-Juarez, PhD, Hospital Universitario Reina Sofia, Cordoba, Spain
 15:05Coffee break
 Session 6: NAFLD and HIV
 15:35NAFLD in HIV- infected patients
Juan Macías, MD, PhD, Hospital de Valme, Seville, Spain
 16:00Abstract - driven presentations
 16:45Discussion
 17:00End of Day 2
   
  

Friday 18 May 2018

 Session 7: Fibrosis markers in liver disease
  9:00The role of Fibroscan: pre and post SVR
Nicolás Merchante, MD, Hospital de Valme, Seville, Spain
 9:25Abstract - driven presentations
 9:40Discussion
 10:00Coffee break
 Session 8: Hepatitis A in HIV
 10:30Roundtable Discussion: Hepatitis A in HIV: the French, Italian, and Spanish Perspective
Massimo Puoti, MD, Niguarda Ca'Granda Hospital, Milan, Italy
Luz Martín-Carbonero, MD, PhD, Hospital Universitario La Paz, Madrid, Spain
 11:15Epidemiology, diagnostics and treatment of Hepatitis E
 11:45Discussion
 12:00Closure
 Invited speakers